World-class API manufacturing facility with 6 blocks catering to Oncology and Non-Oncology APIs with gram-to-kilo scale synthesis capabilities
Shilpa Pharma Life Sciences - Unit I is our flagship API manufacturing facility strategically designed to cater to both Oncology and Non-Oncology Active Pharmaceutical Ingredients along with comprehensive CRAMS (Contract Research And Manufacturing Services) functions.
This state-of-the-art facility represents our commitment to excellence in pharmaceutical manufacturing, featuring world-class infrastructure, advanced containment technologies, and rigorous quality standards that meet global regulatory requirements.
World-class manufacturing blocks comprising 3 dedicated Oncology blocks and 3 Non-Oncology blocks with advanced containment systems
Total reactor capacity of 66,000L (38,000L Non-Oncology + 28,000L Oncology) for efficient large-scale synthesis
Gram-to-kilo scale synthesis competence for flexible production from development to commercial scale
Certified by major international regulatory authorities ensuring worldwide market access
Our Unit I facility offers comprehensive contract services from process development through commercial-scale manufacturing, providing end-to-end support for pharmaceutical companies worldwide.
Our Unit I facility holds approval certificates from the world's most stringent regulatory authorities, ensuring our products meet the highest international quality standards:
The dedicated team of professionals at Unit I, combined with our state-of-the-art infrastructure, ensures that all products are consistently delivered meeting the best industry standard quality. Our quality management system encompasses every aspect of manufacturing from raw material receipt to final product release.
Unit I is strategically positioned on the Hyderabad-Raichur National Highway, providing excellent connectivity for logistics and operations:
